| Factor Information | |
|---|---|
| Data ID | 941 |
| Factor | Cerebral rSO2 25 min before cardiopulmonary resuscitation |
| Description | Cerebral rSO2, however, started decreasing again from approximately 40% to 15% 25 min before cardiopulmonary resuscitation. |
| Biomarker | YES |
| Classification | E10 (physiological factor - other) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | To better foresee cardiac arrest in infants with congenital heart disease, it might be useful to continuously assess end-organ perfusion. |
| Conclusion | These two cases demonstrate that near-infrared spectroscopy might contribute to detecting a deteriorating clinical condition and might therefore be helpful in averting cardiopulmonary collapse and need for resuscitation in infants with congenital heart disease. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 256 |
| CHD Type | non-isolated CHD |
| CHD Subtype | PA, IVS |
| Reference | |
|---|---|
| PMID | 28302079 |
| Year | 2017 |
| Title | Near-infrared spectroscopy as a predictor of clinical deterioration: a case report of two infants with duct dependent congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | infants | |
| Source | a prospective observational cohort study | |
| Region | Groningen, the Netherlands | |
| Method | We measured cerebral and renal rSO2 using INVOS 5100c near-infrared spectrometers (Somanetics Corporation, Troy, Michigan, USA) in combination with neonatal sensors (Somanetics Corporation). | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | case 1(Treatment) | N/A(Control) |
| Number | 1 | N/A |
| Age | 37.3 weeks | N/A |
| Gender (Male: Female) | 1:0 | N/A |
| Marker Level | from 40% to 15% | N/A |
